Your Nervous System Is Running Low: What Magnesium Has to Do With Depression, Anxiety, and Sleep

We’ve spent three articles tracing magnesium through the body: from the periodontium and alveolar bone, through the cardiovascular system, into the metabolic machinery of glucose and insulin. Each stop revealed the same pattern: a mineral so deeply embedded in normal physiology that its absence quietly dismantles one biological system after another.

This final article takes us somewhere that might feel unexpected for a dental hygiene platform. But given that our patients’ oral health is inseparable from their physical health, and their physical health is inseparable from their mental health, I think it belongs here more than almost anywhere.

We’re talking about the brain.

More specifically, it’s about magnesium’s role in the NMDA receptor, the HPA axis, microglial polarization, and the neuroscience of depression and anxiety. And about why some of the most exhausted, most anxious, most overwhelmed patients in our chairs might be dealing with something that is at least partly nutritional.

---

The Nervous System Runs on Magnesium

Here’s a framing device. I want you to carry on with this article.

The nervous system needs to be excitable enough to respond to the environment but not so excitable that it overreacts to everything. It needs to fire when it needs to fire and calm down when it needs to calm down. The balance between excitation and inhibition is the foundation of neurological health.

Magnesium is one of the primary molecules that holds this balance in place.

The main excitatory neurotransmitter system in the brain operates through a receptor called the NMDA receptor (N-methyl-D-aspartate receptor). When glutamate, the brain’s primary excitatory neurotransmitter, binds to the NMDA receptor, calcium floods into the neuron, triggering a cascade of excitatory activity. This is normal, necessary, and how learning, memory formation, and neural plasticity work.

The regulation? Magnesium.

At resting membrane potential, a magnesium ion sits inside the NMDA receptor channel and physically blocks calcium from entering. It’s called the magnesium block, and it’s one of the most elegantly described regulatory mechanisms in all of neuroscience. The neuron has to be sufficiently depolarized (activated enough) to displace the magnesium block and allow calcium through. This ensures that NMDA receptor activation is proportionate; it requires a meaningful signal, not just background noise.

When magnesium is depleted, this block weakens. Calcium flows more freely through NMDA receptors. Neurons become hyperexcitable. The nervous system is easier to trigger and harder to quiet.

The clinical translation: anxiety, hypervigilance, insomnia, panic attacks, irritability, migraines, and sensory sensitivity. All states associated with a nervous system that has lost its ability to modulate excitation. All states are associated with low magnesium in multiple studies.

---

The Research on Depression and Anxiety

The Cureus comprehensive review lists the psychiatric and neurological symptoms associated with magnesium deficiency with a specificity that’s worth reading directly: anxiety, depression, irritability, insomnia, hypochondriasis, panic attacks, hyperexcitability, headache, dizziness, tremors, and psychotic behavior. These aren’t fringe associations. They’re documented, mechanistically plausible, and increasingly supported by clinical evidence.

Here’s what the research shows more specifically:

Depression: Reduced serum magnesium levels have been proposed in subjects with depression. A study by Noah et al. found latent magnesium insufficiency in nearly half of patients screened for stress. Higher magnesium intakes have been associated with reduced depression symptoms in population-level studies. And this is the detail I find most fascinating: some antidepressants like sertraline and amitriptyline appear to increase intracellular magnesium levels. This suggests that part of their therapeutic mechanism may be mediated through magnesium restoration, not just serotonin or norepinephrine modulation.

Anxiety: Magnesium’s NMDA-blocking properties provide a direct mechanistic rationale for its anxiolytic effects. A hyperexcitable nervous system one with inadequate magnesium blocks, is one that responds to low-level stimuli with high-level alarm. Addressing the deficiency dampens that reactivity.

Insomnia: Magnesium acts as a natural NMDA antagonist and GABA agonist. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain. Magnesium facilitates GABA’s calming, sleep-promoting effects while simultaneously reducing the NMDA-driven excitation that keeps the nervous system in an aroused, alert state. This dual mechanism, more inhibition, less excitation, is the neurochemical basis of why magnesium is consistently associated with improved sleep quality.

Dosage studied for mental health and sleep: 200–400 mg/day, with some trials running up to 12 weeks and others longer.

[Source: Al Alawi et al., Cureus, 2024   DOI: 10.7759/cureus.71392]

---

Microglial Polarization: The Neuroinflammation Angle

There’s a more recent layer to the magnesium-mental health story that comes from neuroinflammation research, and it connects directly to the inflammatory biology we’ve been tracing throughout this series.

The brain’s primary immune cells are called microglia. Like macrophages in the peripheral body, microglia can polarize into two broad states: M1 (pro-inflammatory, activating, and harmful at excess) and M2 (anti-inflammatory, neuroprotective, and promoting tissue repair). The balance between M1 and M2 microglial activity is increasingly understood to be a central factor in depression, anxiety, and neurodegenerative disease.

A 2023 study published in the Journal of Neuroinflammation looked at nanoparticulate magnesium hydride in a mouse model of multiple sclerosis, a condition with high rates of anxiety and depression as comorbidities. The magnesium intervention alleviated anxiety and depression-like behaviors, reduced neuroinflammation and demyelination, and did so through a specific, measurable mechanism: it promoted microglial M2 polarization, inhibited M1 polarization, and reduced oxidative stress and mitochondrial damage in the CNS.

This isn’t just an animal model curiosity. It’s mechanistic confirmation that magnesium directly modulates the neuroimmune balance inside the brain, the same balance that is dysregulated in depression, chronic stress, and neuroinflammatory conditions.

[Source: Li Z et al. “Nanoparticulate MgH₂ ameliorates anxiety/depression-like behaviors in a mouse model of multiple sclerosis.” Journal of Neuroinflammation. 2023. DOI: 10.1186/s12974-023-02696-y]

---

The HPA Axis: Stress, Magnesium, and the Feedback Problem

The hypothalamic-pituitary-adrenal (HPA) axis is the body’s central stress response system. When a stressor is perceived, the HPA axis activates, releasing cortisol and other stress hormones. In a healthy system, cortisol eventually feeds back to the hypothalamus and pituitary to shut the response down.

Magnesium is required for this feedback to work properly.

Magnesium has a direct modulatory effect on HPA axis activity. Adequate intracellular magnesium blunts the cortisol response to stressors and supports the negative feedback that turns it off. Deficiency weakens this feedback loop, meaning the cortisol response to stress becomes prolonged, the HPA axis becomes dysregulated, and the nervous system stays in a heightened state longer than it should.

And here’s where it becomes a two-directional problem: cortisol itself increases urinary magnesium excretion. Stress depletes magnesium. Magnesium deficiency worsens the stress response. The more stressed the patient, the more magnesium they lose. The more magnesium they lose, the less equipped their nervous system is to calm down.

This is why the Cureus review notes that enzymes and cellular reactions involved in stress responses are magnesium-dependent   and why researchers have observed reduced serum magnesium in subjects with chronic stress and latent Mg insufficiency in patients screened specifically for stress-related presentations.

The stressed, anxious, exhausted patient in your chair isn’t just “Type A.” They may be running a progressive magnesium deficit that makes their stress physiology worse with every passing month.

---

A Note on the Nutraceutical Guidelines

I want to be transparent with you here, because honest science requires it.

A 2022 clinical guideline from the World Federation of Societies of Biological Psychiatry (WFSBP) and the Canadian Network for Mood and Anxiety Treatments (CANMAT), a taskforce of 31 leading researchers from 15 countries, assessed the evidence for nutraceuticals in psychiatric disorders and categorized magnesium’s evidence for monotherapy in unipolar depression as “not currently recommended” at Grade A level. For comparison, omega-3 fatty acids, methylfolate, and SAMe received stronger recommendations for depression.

I include this because intellectual honesty matters. The evidence for magnesium’s role in depression is mechanistically compelling and epidemiologically supported, but the RCT data for magnesium as a standalone treatment for clinical depression is not yet at the level of omega-3s or folate.

What this does not mean: that magnesium is unimportant for mental health. It means that the research for depression specifically, as a standalone treatment, needs more rigor. The mechanism is real. The associations are real. The case for correcting a deficiency   particularly in patients with high stress, poor sleep, anxiety, and a dietary pattern that depletes magnesium, remains solid.

The nuance is important. We should present the evidence for what it is, not inflate it. And what it clearly is: meaningful enough to warrant attention.

[Source: Sarris J et al. “Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: WFSBP and CANMAT Taskforce.” World Journal of Biological Psychiatry. 2022. DOI: 10.1080/15622975.2021.2013041]

---

What We See Chairside and Why It Matters

This might feel like the furthest reach from dental hygiene practice. But think about the patients you see every day.

The patient who’s grinding their teeth down to nothing, clenching so hard they’ve fractured restorations, whose masseter muscles are like rocks. Their nervous system is hyperexcitable. The magnesium block is part of the story.

The patient mentions every appointment that they’re not sleeping, that they wake up at 3 AM with their mind racing and their jaw clenched. The GABA-NMDA imbalance is worth thinking about.

The patient who’s been on an antidepressant for years comes in with xerostomia, elevated caries risk, and periodontal changes, some of which may be medication-related and some of which may reflect the underlying inflammatory state that drove them to seek mental health treatment in the first place. Magnesium is threading through all of it.

We are not mental health clinicians. We are not prescribing supplements or recommending specific interventions for depression and anxiety.

But we are clinicians who see patients in a sustained, recurring, intimate clinical setting where they often feel comfortable sharing things they don’t share elsewhere. When someone mentions they haven’t slept properly in months, or that their anxiety has been out of control, or that they’re exhausted in a way that rest doesn’t fix, we can do more than hand them a brochure.

We can ask about their diet. We can connect the dots between what we see clinically and the systemic picture we know from the science. We can be the clinician who says: “There’s emerging research that connects magnesium deficiency to sleep, anxiety, and fatigue   and most people with this kind of pattern are running low. That’s worth bringing up with your doctor.”

That’s not overstepping. That’s exactly what functional, whole-person dental hygiene looks like.

---

Pulling the Series Together

Over four articles, we’ve traced magnesium from the oral microenvironment to the cardiovascular system to the metabolic machinery to the nervous system. And what’s emerged isn’t a story about a supplemental mineral that does a few nice things.

It’s a story about a foundational nutrient cofactor to over 600 enzymatic reactions, essential for MgATP, for NMDA regulation, for RANKL/OPG balance, for eNOS activation, for insulin receptor kinase function that a majority of Americans are chronically running low on. And the biological consequences of that deficiency are not isolated. They compound. They interact. They manifest in the very patients sitting across from us in the operatory every single day.

The oral-systemic connection has always been the lens through which I approach this work. Magnesium is one of the clearest, most thoroughly researched examples of that connection in action.

When we see the mouth, we are seeing the body. When we see persistent inflammation, progressive bone loss, and recalcitrant disease that doesn’t match the biofilm burden   the body is trying to tell us something.

Magnesium might just be the message.

---

Practical Takeaways for the Full Series

Who is most at risk for magnesium deficiency:

• Adults eating a Western diet (processed food, low whole grains, low vegetables)
• People under chronic stress (cortisol depletes magnesium)
• Patients with type 2 diabetes (hyperglycemia flushes it; insulin resistance blocks cellular uptake)
• Patients on diuretics, PPIs, H2 blockers, antibiotics, anticonvulsants
• Older adults (reduced absorption, increased excretion, multiple medications)
• Pregnant women (increased demand)
• Heavy exercisers (sweat losses)

Best food sources: Pumpkin seeds, almonds, cashews, dark leafy greens (spinach, Swiss chard), black beans, lentils, quinoa, whole oats, dark chocolate, mineral-rich water

Supplementation guidance:

• Choose forms with high bioavailability: magnesium glycinate (best for sleep/anxiety, gentlest on gut), magnesium citrate (good absorption), magnesium malate (well-tolerated, energy metabolism)
• Avoid magnesium oxide   cheapest and least absorbed
• Typical therapeutic ranges: 200–600 mg/day depending on indication
• Always consult a healthcare provider for patients with kidney disease, heart disease, or on multiple medications

Test your Magnesium here. Use AmberA10 at checkout.

---

This series is educational and not intended as individualized medical advice. Please consult your healthcare provider before beginning any supplementation regimen.

Disclosure: I partner with Equilife because I use and trust their formulations   particularly for high-quality, bioavailable supplementation. If you purchase through my link, I may earn a commission at no additional cost to you. The science always comes first.

---

The Science

Based on research retrieved from PubMed:

1. Al Alawi AM et al. “Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases.” Cureus. 2024. DOI: 10.7759/cureus.71392

2. Li Z et al. “Nanoparticulate MgH₂ ameliorates anxiety/depression-like behaviors in a mouse model of multiple sclerosis by regulating microglial polarization and oxidative stress.” Journal of Neuroinflammation. 2023. DOI: 10.1186/s12974-023-02696-y

3. Sarris J et al. “Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The WFSBP and CANMAT Taskforce.” World Journal of Biological Psychiatry. 2022. DOI: 10.1080/15622975.2021.2013041

---

Amber Auger, MPH, RDH, Functional Hygienist, clinician, speaker, and relentless advocate for the whole-person patient.

If this series landed with you, share it with a colleague who needs to see it. The conversation about oral-systemic health starts in our chairs. Let’s keep it going.